An 82-year-old male patient was admitted for liver dysfunction. Laboratory test showed the following data; aspartate aminotransferase (AST) 79 IU//, alanine aminotransferase (ALT) 28 IU//, total bilirubin (T. Bil) 0.9 U, zinc sulfate turbidity test (ZTT) 48.9 U, y-globulin 4.9 g/dl, immunoglobulin G (IgG) 5,046 mg/dl, anti-nuclear antibodiesx320, anti-mitochondrial antibodies (-), hepatitis B virus surface antigen (HBsAg) (-), HBcAb (-), anti-hepatitis C virus (anti-HCV) (-), hepatitis C virus (HCV-RNA) (-), anti-hepatitis G virus (anti-HGV) (-), oc-fetoprotein 306.8 ng/ml, carcinoembryonic antigen (CEA) 2.3 ng/ml, carbohydrate antigen (CA) 19-9 77.2 U/ ml. Abdominal ultrasonography and computed tomography showed a large mass occupying most of the right lobe and portal thrombosis in the liver. Liver biopsy revealed cirrhosis with inactive hepatitis in the nontumorous lesion and well-differentiated hepatocellular carcinoma in the tumorous lesion. Wereport a rare case of an aged male patient with autoimmunehepatitis complicated by hepatocellular carcinoma. (Internal Medicine 38: 422-425, 1999) 
Introduction
Autoimmue hepatitis (AIH) occurs predominantly in females, especially in post menopausal woman, in Japan (1) . Hepatitis B and C are the most important factors for the development of hepatocellular carcinoma (HCC), and it is very rare for HCCto develop in patients with AIH (2) (3) (4) (5) (6) (7) (8) (9) . Wereport a case of an aged manwith AIHcomplicated by HCC.
Case Report
An 82-year-old man had been followed for liver dysfunction since 1974, of which the etiology had been unknown. He had not been pointed out to have obvious jaundice. He was admitted to our hospital in April 1997 due to general malaise. There was a history of neither alcohol abuse nor blood transfusion.
Physical examination on admission revealed anemia but not jaundice. The liver was enlarged and extended 3 cm below the right costal margin. Spleen and kidneys were not palpable. He had spider angiomata on the chest and shoulders. Ascites and peripheral edemawere not present.
Pertinent laboratory data revealed aspartate aminotransferase (AST) 79 IU//, alanine aminotransferase (ALT) 28 IU/Z, total bilirubin 0.9 mg/dl, zinc sulfate turbidity test (ZTT) 48.9 U, yglobulin 4.9 g/dl, immunoglobulin G (IgG) 5,046 mg/dl. Test results for hepatitis B surface antigen (HBsAg), anti-hepatitis B core antibodies, anti-hepatitis C virus antibodies (anti-HCV), hepatitis C virus RNA(HCV-RNA), hepatitis G virus RNA (HGV-RNA), as well as the results of tests for antimitochondrial antibodies, were negative. However, results were positive for antinuclear antibodies (ANA), with a titer of l :320.oc-fetoprotein was 306.8 IU/ml, carbohydrate antigen 19-9 was 77 U/ml and serum carcinoembryonic antigen was 2.9 ng/ml ( Table 1) .
Abdominal ultrasonography (US) (Fig. 1 ) and abdominal computed tomography (CT) (Fig. 2) showed a large mass occupying most of the right lobe and portal thrombosis in the liver.
Liver biopsy was performed to difine the diagnosis. A liver biopsy specimen showed cirrhosis with minimal chronic inflammatory cell infiltration in the portal tract in the non-tumorouslesion and well-differentiated hepatocellular carcinoma in the tumorous lesion (Fig. 3) . Selective hepatic angiography showed a large (diameter; Aged Male Patient with AIH Complicated by HCC Table 1 . Laboratory Data on Admission CEA: serum carcinoembryonic antigen, CA1 9-9: carbohydrate antigen 1 9-9, AFP: Alpha-fetoprotein. and massive bloody ascites was seen! The diameter of the tumor in the right lobe was 10 cm and portal thrombosis was seen. Noextrahepatic metastases were noted. The tumor had the same histologic features as the biopsy specimen. The nontumorouslesion of the liver showedcirrhosis with minimal inflammatory cell infiltration (Fig. 5) . Immunohistochemistry for HBsAg, HBcAg and hepatitis C virus (HCV) core antigen was shown to be negative in the liver obtained by autopsy.
Discussion
Risk factors for the development of HCCare the male gender and long-standing cirrhosis (10) . Other factors commonly associated with HCCare hepatitis B virus (HBV) (ll-13) and HCV ( 14, 15) . In particular HCVis the most common factor in Japan (16) . On the other hand, it is rare that HCCcomplicates AIHin spite of the fact that patients sometimes have cirrhosis for manyyears. The reason has previously been explained by the predominance of females with the disease and the lack of a continuing inflammatory process because of effective treatment with immunosuppressants (4).
Recently case reports of primary biliary cirrhosis (PBC) complicated by HCChave been increasing (17) . Those ofAIH complicated by HCChave also been increasing, however, it is revealed retrospectively that HCVmarkers are frequently positive in these cases (18) . To our knowledge, though Yousuf et al reported the first case of HCVnegative HCCassociated with AIH in English (19) , neither HCV-RNAnor HGV-RNAwas mentioned. The current case is negative for HGV-RNA as well as HCV-RNA. To rule out HBVand HCVinfection completely, both of these viruses must be negative in the liver tissue (18) . In the present case, the diagnosis of liver cirrhosis due to autoimmunity had been suggested as judged by the clinical data including high titers of ANAand massively increased gammaglobulin, and both HBVand HCVwere negative in the liver tissue obtained by autopsy. However, it is necessary to investigate the integration of HBVgenome in the liver tissue to rule out the possibility of HBVinfection. Additionally, Seki et al (20) have reported that autoimmunity may be induced as a paraneoplastic syndrome in HCC patients with a marked elevation of serum interleukin-6 levels. The histopathological feature of those HCCis a so-called "sclerosing type" that showsmoderate to poor differentiation and markedly increased extracellular matrices, but the present case was well-differentiated HCC. A marked increase in serum C-Aged Male Patient with AIH Complicated bv HCC reactive protein and an accelerated erythrocyte sedimentation rate were frequently observed in their study, but the present case showedonly a slight elevation of these data.
The score of International AutoimmuneHepatitis Group (2 1 ) is more than 15 points before treatment, which indicates definite AIH. The present patient already had established cirrhosis on admission. Though the time of the occurrence ofAIH is unkown, he had suffered from liver dysfunction for more than 20 years. Therefore, the duration of the hepatitis seems to be relatively long. These facts suggest that the present case is AIH complicated by HCCrather than paraneoplastic syndrome. Burroughs et al reported that HCCmust be considered as a possible cause of clinical deterioration in patients with longstanding autoimmune chronic liver disease (22) . Another factor that mayinfluence the prevalence of HCCis corticosteroid therapy, which may impair oncologic immunity mediated host defense mechanisms (9) . In the present case, however, corticosteroid therapy was not done. In summary,we reported an old manwith AIHcomplicated by HCC.The present case adds information on the occurrence of HCCin AIH. Therefore, screening for HCCshould also be performed in patients with AIHthe same as with cirrhosis caused by HBVor HCV.
